Relationship between the intracellular level and growth inhibition of a new anthracycline 4′O-tetrahydropyranyl-adriamycin in friend leukemia cell variants
- 1 January 1985
- journal article
- research article
- Published by Elsevier in Leukemia Research
- Vol. 9 (2), 289-296
- https://doi.org/10.1016/0145-2126(85)90091-8
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Fate of aclacinomycin-A and its metabolites effect on cell growth and macromolecular synthesisBiochemical Pharmacology, 1983
- Rapid determination of doxorubicin and its fluorescent metabolites by high pressure liquid chromatographyAnalytical Biochemistry, 1979
- Low heart and skin toxicity of a tetrahydropyranyl derivative of adriamycin (THP-ADM) as observed by electron and light microscopy.The Journal of Antibiotics, 1979
- Uptake and subcellular localization of daunorubicin and adriamycin in cultured fibroblastsEuropean Journal of Cancer (1965), 1978
- Uptake and retention of adriamycin and daunorubicin by sensitive and anthracycline-resistant sublines of P388 leukemiaBiochemical Pharmacology, 1978
- Transport and binding of daunorubicin, adriamycin, and rubidazone in ehrlich ascites tumour cellsBiochemical Pharmacology, 1977
- Adriamycin—A ReviewJNCI Journal of the National Cancer Institute, 1975
- The Clinical Pharmacology of Antineoplastic AgentsNew England Journal of Medicine, 1975
- AdriamycinAnnals of Internal Medicine, 1974
- A clinicopathologic analysis of adriamycin cardiotoxicityCancer, 1973